Neuroscience
From FierceBiotech:
Fluorescent peptides help nerves glow in surgery
08 February 2011
Read the press release
- Alzheimer's Disease: Negative Bapineuzumab Findings In Phase Iii Trial
Critical reading for those interested in Alzheimer's clinical trials: first results from the BAP Phase III program. The link includes additional links to a New York Times article and a company press release. From FierceBiotech: UPDATED: Pfizer, J&J...
- Will There Be Biotechs "emerging From The Rubble At Sandwich"?
Investors ready to craft new biotechs out of Pfizer's discards February 9, 2011 — 8:47am ET By John Carroll FierceBiotech Read the article...
- "care Innovations"- A New Joint Ge-intel Project
An Intel press release on the 3rd of January: Read press release According the the press release, "Care Innovations will develop technologies that support healthy, independent living at home and in senior housing communities."...
- Fda Rejects Ezogabine
FDA rejects a new epilepsy drug from Valeant, GSK FierceBiotech 02 December 2010 Read FierceBiotech article here === Earlier blog post on topic, from 12th August: here ===...
- Fda Approves Multiple Sclerosis Drug, Ampyra (dalfampridine) Extended-release
From FierceBiotech: FDA approves Acorda's new MS drug January 22, 2010 — 4:49pm ET By John Carroll [snip] The FDA announced Friday afternoon that it has approved Ampyra (dalfampridine) extended-release tablets to improve walking in patients with...
Neuroscience
Preventing Surgical Nerve Damage
From FierceBiotech:
Fluorescent peptides help nerves glow in surgery
08 February 2011
Read the press release
- Alzheimer's Disease: Negative Bapineuzumab Findings In Phase Iii Trial
Critical reading for those interested in Alzheimer's clinical trials: first results from the BAP Phase III program. The link includes additional links to a New York Times article and a company press release. From FierceBiotech: UPDATED: Pfizer, J&J...
- Will There Be Biotechs "emerging From The Rubble At Sandwich"?
Investors ready to craft new biotechs out of Pfizer's discards February 9, 2011 — 8:47am ET By John Carroll FierceBiotech Read the article...
- "care Innovations"- A New Joint Ge-intel Project
An Intel press release on the 3rd of January: Read press release According the the press release, "Care Innovations will develop technologies that support healthy, independent living at home and in senior housing communities."...
- Fda Rejects Ezogabine
FDA rejects a new epilepsy drug from Valeant, GSK FierceBiotech 02 December 2010 Read FierceBiotech article here === Earlier blog post on topic, from 12th August: here ===...
- Fda Approves Multiple Sclerosis Drug, Ampyra (dalfampridine) Extended-release
From FierceBiotech: FDA approves Acorda's new MS drug January 22, 2010 — 4:49pm ET By John Carroll [snip] The FDA announced Friday afternoon that it has approved Ampyra (dalfampridine) extended-release tablets to improve walking in patients with...